Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
18F-2-fluoro-2-deoxy-D-glucose
- Development stage
- Unknown
- Lead developer
- Eastern Health
- Modality
- Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
- Administration
- Intravenous
01
Overview
18F-2-fluoro-2-deoxy-D-glucose (18F-FDG) is a radiopharmaceutical glucose analog used in positron emission tomography (PET) imaging. Developed and produced locally by Eastern Health in Newfoundland and Labrador, Canada, this specific formulation is intended to improve patient access to diagnostic imaging within the province. The molecule is transported into cells by glucose transporters (GLUTs) and subsequently phosphorylated by hexokinase. Due to the substitution of a hydroxyl group with a fluorine-18 isotope at the C-2 position, the resulting 18F-FDG-6-phosphate cannot be further metabolized via glycolysis and remains trapped within the cell. This metabolic trapping allows for the visualization and quantification of glucose consumption in tissues, making it a vital tool for the diagnosis and staging of various conditions, including malignant tumors, neurological disorders, and inflammatory diseases.
- Other names
- fludeoxyglucose F 182-deoxy-2-(18F)fluoro-D-glucosefluorodeoxyglucose18F-2-fluoro-2-deoxy-D-glucose-Eastern Health, Canada
02
Targets
GLUT (Glucose transporter family)GCK (Glucokinase)
Beyond the preview
Go deeper on 18F-2-fluoro-2-deoxy-D-glucose.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 18F-2-fluoro-2-deoxy-D-glucose.